Cargando…
Spironolactone (an adjuvant therapy) in rheumatoid arthritis: a case control study
OBJECTIVES: Disease-modifying anti-rheumatic drugs (DMARDs) are conventionally used in rheumatoid arthritis (RA). The role of spironolactone as add on therapy to DMARDs in RA patients was evaluated. MATERIAL AND METHODS: A total of 100 patients with rheumatoid arthritis diagnosed as per 1987 criteri...
Autores principales: | Singh, Harpreet, Bala, Saroj, Jain, Deepak, Jagota, Ruchi, Mathur, Rekha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974630/ https://www.ncbi.nlm.nih.gov/pubmed/29853723 http://dx.doi.org/10.5114/reum.2018.75519 |
Ejemplares similares
-
Agranulocytosis Associated With Spironolactone Therapy: A Case Report
por: Fershko, Adam A., et al.
Publicado: (2011) -
Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan
por: Makhlough, Atieh, et al.
Publicado: (2014) -
The effect of spironolactone on diastolic function in haemodialysis patients
por: Hauser, T., et al.
Publicado: (2021) -
Scrub Typhus Infection: An Inciting Agent for Posterior Reversible Encephalopathy Syndrome?
por: Jain, Rajendra Singh, et al.
Publicado: (2021) -
Furosemide/spironolactone: Hypotension: case report
Publicado: (2022)